Nvidia Could Surpass Microsoft in Market Value, Says Jim Cramer: Here’s Why

Nvidia (NVDA) may surpass Microsoft's (MSFT) market cap, as its importance in AI, cloud computing, and data centers grows. Stock rose 186% in a year.

According to CNBC’s Jim Cramer, Nvidia Corp (NASDAQ:MSFT) market capitalization. He explained that Wall Street is skeptical of Nvidia’s rapid rise, as many need to familiarize themselves with its products.

Cramer compared Nvidia’s ascent to Apple Inc’s (NASDAQ:XOM), noting that Nvidia’s fame primarily comes from the enterprise sector and hard-core gamers, CNBC reports.

Also Read: AMD Expands Partnership with Samsung, New 3nm Chips to Boost Market Share

Cramer emphasized that Nvidia’s significance extends beyond gaming. He highlighted Nvidia’s pivotal role in artificial intelligence, cloud computing, and data centers, which drive its growth.

“Nvidia’s chips are the backbone of AI advancements and have become essential for tech companies and industries worldwide,” Cramer said.

Cramer noted, “Nvidia’s potential is immense, and its products are increasingly becoming integral to the tech infrastructure, making it a company that could redefine the future of technology.”

TSM) battles supply constraints regarding Chip on Wafer on Substrate (CoWoS) packaging.

Analysts noted Nvidia as the key AI beneficiary backed by Blackwell chip production pipeline and U.S. Big Tech customers including Amazon.Com Inc (NASDAQ:META), Microsoft.

Nvidia stock gained over 186% in the last 12 months. Investors can gain exposure to the stock via VanEck Semiconductor ETF (NASDAQ:DARP).

Price Actions: NVDA shares were trading lower by 0.43% at $1,143.31 premarket at the last check on Thursday.

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Photo via Wikimedia Commons

Total
0
Shares
Related Posts
Read More

CBD Giant’s Challenging Year: Q4 Net Sales Slide By 27% But Net Loss Narrows 67% YoY

cbdMD reported a 27% year-over-year drop in net sales for the fourth quarter of 2023, totaling $5.7 million. The company attributed the decline to industry trends, reduced marketing spend, and lower wholesale pricing for its new high-strength products. For the full fiscal year 2023, net sales reached $24.2 million, down from $35.4 million in the previous year. Gross profit for the year was approximately $15 million, a decrease from $22.3 million in fiscal 2022. The company reported a net loss of about $23 million, compared to $70 million in 2022. Operating expenses fell to $24.2 million from $40 million in the prior year. cbdMD's working capital on September 30, 2023, was $3.4 million, down from $10.7 million on the same date in 2022. The company also launched its hempMD and ATRx brands in 2023, expanding its product channels into Amazon and other consumer products channels.

YCBD